Developer docs
API playgroundTry for free, no card

Search company profiles

Gencor

Full company profile

uuid000byn4

Namestring
Gencor
Legal namestring
Gencor
Company typeenum
Private
Founded yearint
2001
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAnaheim, United States
HQ citystring
Anaheim
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
nutraceutical ingredients, botanical extracts supplier, bioavailability technologies, branded dietary ingredients, clinical study ingredients
Industry2 codes
1Herbal & Botanical Supplements
CodeCRADAGADPrimaryYes
2Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin)
CodeAFAJAKAKPrimaryNo
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutraceutical Ingredients
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Proprietary Ingredient Sales
TypeLicensing Royalties
Description

Sale of branded botanical ingredient extracts to supplement manufacturers and finished product brands. Revenue generated through ingredient licensing and supply contracts.

nutraingredients.com
2Delivery Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary delivery technologies (AquaCelle, LipiSperse, CPO) to supplement manufacturers for enhanced bioavailability of their formulations.

saanroo.com
3Distribution Revenue
TypeTransaction Fee
Description

Distribution of branded ingredients from partner suppliers (e.g., Pharmactive's Affron saffron extract) in North American markets through Gencor Pacific.

supplysidesj.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1AquaCelle
Description

Patent-pending, clinically-validated self micro-emulsifying drug delivery system (SMEDDS) designed to increase bioavailability of lipophilic actives. Trademark of Pharmako Biotechnologies Pty Ltd.

saanroo.com
+2 more records
Core offering1 text field

Gencor (now operating as Saanroo) is a B2B supplier of proprietary branded botanical ingredients and proprietary delivery technologies to supplement manufacturers, formulators, and finished product brands globally. Its portfolio includes 21 clinically studied branded ingredients (e.g., Levagen, HydroCurc, Testofen, affron, Slimaluma, Libifem, HairAge) and 4 delivery technologies (AquaCelle, LipiSperse, CPO, PlexoZome) that improve the bioavailability of fat-soluble nutraceutical actives.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 11.5% global CAGR projected for hair health supplements market (2021-2031)
+3 more records
Product overview1 text field

Gencor, now operating as Saanroo, is a B2B supplier of proprietary branded botanical ingredients and proprietary delivery technologies to manufacturers and formulators in the nutraceutical and supplement industries. The portfolio includes 21 branded ingredients (Levagen®, HydroCurc®, Testofen®, affron®, Slimaluma®, Libifem®, Genopause®, AGEprost™, Tesnor®, ActivAMP®, Gencinia®, VeriSperse®, CALMaluma™, HairAge®, 4Liver™, DermaNiA®, Trigogen®, Trpti™, BioBerb®) and 4 delivery technologies (AquaCelle®, LipiSperse®, CPO®, PlexoZome®). Ingredients are clinically studied and target applications across sport nutrition, healthy aging, cognitive health, women's and men's health, internal/metabolic health, immune health, and skin health. Delivery technologies enhance bioavailability of lipophilic actives through micro-emulsification, cold water dispersion, and compressed powder formats.

Product and service6 records
1Levagen®
CategoryBranded Ingredient
Description

A proprietary palmitoylethanolamide (PEA) ingredient supporting joint health, immune function, and sleep, supplied to supplement manufacturers and finished product brands.

2HydroCurc®
CategoryBranded Ingredient
Description

A bioavailable curcumin ingredient using LipiSperse technology for enhanced absorption, supporting healthy aging and mobility, supplied to supplement manufacturers.

3Testofen®
CategoryBranded Ingredient
Description

A standardized fenugreek extract supporting testosterone levels and male health, supplied to supplement manufacturers.

4affron®
CategoryBranded Ingredient
Description

A branded saffron extract clinically studied for mood support and mild depression symptoms, distributed by Gencor Pacific in North America.

5Slimaluma®
CategoryBranded Ingredient
Description

A Garcinia cambogia extract for weight management and appetite support, supplied to supplement manufacturers.

6Libifem®
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Partnership for proprietary delivery technologies including AquaCelle (SMEDDS), LipiSperse (cold water dispersion), and CPO (compressed powdered oils). These technologies enhance bioavailability of lipophilic actives in nutraceutical formulations. Pharmako Biotechnologies Pty Ltd owns trademarks for these technologies.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ Distributor
Description

Gencor Pacific distributes Pharmactive's branded Affron saffron extract in North American markets. Affron is a clinically studied saffron extract for mild depression demonstrated in a 12-week placebo-controlled trial published in the Journal of Nutrition.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AIDP is a US-based value-added nutraceutical ingredient distributor and supplier of branded ingredients (e.g., Magtein, PreticX, KoAct) with a comparable B2B model and similar customer base of supplement manufacturers.

TypeDirect peer
Description

Sabinsa is a leading global B2B supplier of branded, clinically validated nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine, ForsLean) with a licensing-and-supply model that closely mirrors Gencor's go-to-market.

TypeDirect peer
Description

OmniActive supplies proprietary branded ingredients (Lutemax, BioCurc, Capsimax) to supplement manufacturers, competing head-to-head with Gencor's HydroCurc, Testofen, and Slimaluma in the branded-ingredients channel.

TypeBroad incumbent
Description

Kerry is a large taste-and-nutrition ingredient platform with a meaningful health-and-wellness portfolio serving supplement and functional-food brands; overlaps with Gencor on botanical extracts and bioavailability-enhanced ingredients, with significantly broader scale.

TypeDirect peer
Description

PLT Health markets branded, science-backed nutraceutical ingredients (e.g., Zembrin, Dynalife, Sleeproot) into the same supplement-manufacturer channel, with a portfolio-and-licensing model that closely resembles Gencor's.

TypeBroad incumbent
Description

Glanbia Nutritionals is a large, diversified ingredient supplier serving the same supplement brands with proteins, premixes, and bioactives; overlaps with Gencor on the supplement-manufacturer customer base but at much broader scale.

TypeBroad incumbent
Description

Lonza supplies encapsulated and health ingredients (including bioavailability-enhanced formats) to nutraceutical brands globally; competes with Gencor's AquaCelle/LipiSperse positioning in delivery technology and bioavailability.

TypeBroad incumbent
Description

Naturex, now part of Givaudan, is a large supplier of plant-based specialty ingredients for nutrition and health, competing with Gencor in standardized botanical extracts but with a much broader portfolio and global R&D footprint.

TypeRegional player
Description

Pharmactive is a Spanish developer of branded saffron (Affron) and other botanical extracts, and currently distributes through Gencor Pacific in North America — making it a partial collaborator and a potential direct competitor as Pharmactive scales its own channel.

TypeEmerging player
Description

DolCas Biotech is a smaller US-based supplier of branded botanical extracts (e.g., Curcumin C3 Complex-adjacent ingredient lines) targeting the same B2B supplements market, with partial overlap in botanical curcumin and bioavailability claims.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gencor

Nutraceutical Ingredientsgencorpacific.com

Gencor firmographics

Firmographics
Name
Gencor
Legal name
Gencor
Website
https://gencorpacific.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Gencor industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Herbal & Botanical Supplements (CRADAGAD)
akta.pro secondary industry
Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK)

Keywords

  • Nutraceutical ingredients
  • Botanical extracts supplier
  • Bioavailability technologies
  • Branded dietary ingredients
  • Clinical study ingredients

Where Gencor is headquartered

Location

Headquarters

HQ city
Anaheim
HQ country
United States
HQ region
North America

Markets served

Gencor business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Proprietary Ingredient Sales: Sale of branded botanical ingredient extracts to supplement manufacturers and finished product brands. Revenue generated through ingredient licensing and supply contracts.
  2. Delivery Technology Licensing: Licensing of proprietary delivery technologies (AquaCelle, LipiSperse, CPO) to supplement manufacturers for enhanced bioavailability of their formulations.
  3. Distribution Revenue: Distribution of branded ingredients from partner suppliers (e.g., Pharmactive's Affron saffron extract) in North American markets through Gencor Pacific.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Gencor product offering

Product offering

Core offering

Gencor (now operating as Saanroo) is a B2B supplier of proprietary branded botanical ingredients and proprietary delivery technologies to supplement manufacturers, formulators, and finished product brands globally. Its portfolio includes 21 clinically studied branded ingredients (e.g., Levagen, HydroCurc, Testofen, affron, Slimaluma, Libifem, HairAge) and 4 delivery technologies (AquaCelle, LipiSperse, CPO, PlexoZome) that improve the bioavailability of fat-soluble nutraceutical actives.

Product overview

Gencor, now operating as Saanroo, is a B2B supplier of proprietary branded botanical ingredients and proprietary delivery technologies to manufacturers and formulators in the nutraceutical and supplement industries. The portfolio includes 21 branded ingredients (Levagen®, HydroCurc®, Testofen®, affron®, Slimaluma®, Libifem®, Genopause®, AGEprost™, Tesnor®, ActivAMP®, Gencinia®, VeriSperse®, CALMaluma™, HairAge®, 4Liver™, DermaNiA®, Trigogen®, Trpti™, BioBerb®) and 4 delivery technologies (AquaCelle®, LipiSperse®, CPO®, PlexoZome®). Ingredients are clinically studied and target applications across sport nutrition, healthy aging, cognitive health, women's and men's health, internal/metabolic health, immune health, and skin health. Delivery technologies enhance bioavailability of lipophilic actives through micro-emulsification, cold water dispersion, and compressed powder formats.

Differentiator

Problem solved

Functional benefit

Brands

  • AquaCelle: Patent-pending, clinically-validated self micro-emulsifying drug delivery system (SMEDDS) designed to increase bioavailability of lipophilic actives. Trademark of Pharmako Biotechnologies Pty Ltd.
  • LipiSperse
  • CPO

Products and services

  • Levagen® A proprietary palmitoylethanolamide (PEA) ingredient supporting joint health, immune function, and sleep, supplied to supplement manufacturers and finished product brands.
  • HydroCurc® A bioavailable curcumin ingredient using LipiSperse technology for enhanced absorption, supporting healthy aging and mobility, supplied to supplement manufacturers.
  • Testofen® A standardized fenugreek extract supporting testosterone levels and male health, supplied to supplement manufacturers.
  • affron® A branded saffron extract clinically studied for mood support and mild depression symptoms, distributed by Gencor Pacific in North America.
  • Slimaluma® A Garcinia cambogia extract for weight management and appetite support, supplied to supplement manufacturers.
  • Libifem®

Quantifiable outcome

  • 11.5% global CAGR projected for hair health supplements market (2021-2031)
  • +3 more outcomes

Companies that use Gencor

Customer profile

Named customers2 records

Segments8 records

Ideal customer profiles1 record

Gencor technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Gencor partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • Pharmako BiotechnologiescoreTechnology or IntegrationPartnership for proprietary delivery technologies including AquaCelle (SMEDDS), LipiSperse (cold water dispersion), and CPO (compressed powdered oils). These technologies enhance bioavailability of lipophilic actives in nutraceutical formulations. Pharmako Biotechnologies Pty Ltd owns trademarks for these technologies.
  • PharmactiveflagshipChannel Partner/ Reseller/ DistributorGencor Pacific distributes Pharmactive's branded Affron saffron extract in North American markets. Affron is a clinically studied saffron extract for mild depression demonstrated in a 12-week placebo-controlled trial published in the Journal of Nutrition.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Gencor competitors and assessment

Company assessment

Direct peers

  • AIDP Inc. AIDP is a US-based value-added nutraceutical ingredient distributor and supplier of branded ingredients (e.g., Magtein, PreticX, KoAct) with a comparable B2B model and similar customer base of supplement manufacturers.
  • Sabinsa: Sabinsa is a leading global B2B supplier of branded, clinically validated nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine, ForsLean) with a licensing-and-supply model that closely mirrors Gencor's go-to-market.
  • OmniActive Health Technologies: OmniActive supplies proprietary branded ingredients (Lutemax, BioCurc, Capsimax) to supplement manufacturers, competing head-to-head with Gencor's HydroCurc, Testofen, and Slimaluma in the branded-ingredients channel.
  • PLT Health Solutions: PLT Health markets branded, science-backed nutraceutical ingredients (e.g., Zembrin, Dynalife, Sleeproot) into the same supplement-manufacturer channel, with a portfolio-and-licensing model that closely resembles Gencor's.

Broad incumbents

  • Kerry Group: Kerry is a large taste-and-nutrition ingredient platform with a meaningful health-and-wellness portfolio serving supplement and functional-food brands; overlaps with Gencor on botanical extracts and bioavailability-enhanced ingredients, with significantly broader scale.
  • Glanbia Nutritionals: Glanbia Nutritionals is a large, diversified ingredient supplier serving the same supplement brands with proteins, premixes, and bioactives; overlaps with Gencor on the supplement-manufacturer customer base but at much broader scale.
  • Lonza Capsules & Health Ingredients: Lonza supplies encapsulated and health ingredients (including bioavailability-enhanced formats) to nutraceutical brands globally; competes with Gencor's AquaCelle/LipiSperse positioning in delivery technology and bioavailability.
  • Naturex (Givaudan): Naturex, now part of Givaudan, is a large supplier of plant-based specialty ingredients for nutrition and health, competing with Gencor in standardized botanical extracts but with a much broader portfolio and global R&D footprint.

Regional players

  • Pharmactive Biotech Products: Pharmactive is a Spanish developer of branded saffron (Affron) and other botanical extracts, and currently distributes through Gencor Pacific in North America — making it a partial collaborator and a potential direct competitor as Pharmactive scales its own channel.

Emerging players

  • DolCas Biotech: DolCas Biotech is a smaller US-based supplier of branded botanical extracts (e.g., Curcumin C3 Complex-adjacent ingredient lines) targeting the same B2B supplements market, with partial overlap in botanical curcumin and bioavailability claims.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Gencor social profiles

Digital presence

Gencor financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gencor leadership team

Management profile

Number of profiles

Gencor funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gencor M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gencor

What does Gencor do?

Gencor (now operating as Saanroo) is a B2B supplier of proprietary branded botanical ingredients and proprietary delivery technologies to supplement manufacturers, formulators, and finished product brands globally. Its portfolio includes 21 clinically studied branded ingredients (e.g., Levagen, HydroCurc, Testofen, affron, Slimaluma, Libifem, HairAge) and 4 delivery technologies (AquaCelle, LipiSperse, CPO, PlexoZome) that improve the bioavailability of fat-soluble nutraceutical actives.

Is Gencor a public or private company?

Gencor is a private company. It is classified as unknown and is currently operating.

When was Gencor founded?

Gencor was founded in 2001. It employs 11 to 50 people.

Where is Gencor based?

Gencor is headquartered in Anaheim, United States, in the North America region.

How does Gencor make money?

Three revenue lines are on record. Proprietary Ingredient Sales are the primary driver. The others are delivery Technology Licensing and distribution Revenue.

Who are Gencor's main competitors?

Direct peers on record are AIDP Inc., Sabinsa, OmniActive Health Technologies and PLT Health Solutions. Broad incumbents are Kerry Group, Glanbia Nutritionals, Lonza Capsules & Health Ingredients and Naturex (Givaudan). Pharmactive Biotech Products is listed as a regional player. DolCas Biotech is listed as an emerging player.

Does Gencor have an API?

No public API is recorded for Gencor.

What industry is Gencor in?

Gencor's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements, with a secondary code of AFAJAKAK, Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nutritional OutlookIs hair health now the star of natural beauty supplements?The hair health supplements market is experiencing rapid growth, with Transparency Market Research estimating an 11.5% global CAGR between 2021 and 2031, driven by increased consumer awareness of nutrition's role in hair health. Several companies are responding with new product launches and ingredient innovations: Nutrafol introduced Collagen Infusion, a collagen-based powdered mix for hair health; ingredient supplier Gencor launched HairAge Vitae, a branded Ageratum conyzoides extract based on traditional Indian folk remedies; and Sabinsa Corp developed LactoSporin, a postbiotic ingredient being studied for hair growth applications. The industry trend is shifting toward research-validated ingredients, with companies investing in clinical trials to build consumer trust through scientifically-backed formulations.openPR.comFenugreek Fiber Market to Reach USD 262.6 Million by 2036 as Clean-Label Food Innovation and Industrial Applications Expand DemandFuture Market Insights released a market analysis projecting the global fenugreek fiber market to grow from USD 177.9 million in 2025 to USD 262.6 million by 2036, reflecting a compound annual growth rate of 3.6%. Artemis International launched Fenuflakes in April 2025, a de-bitterized fenugreek seed product targeting clean-label bakery, pasta, and cereal formulations, while Gencor expanded its Trigogen extract positioning and Emerald Seed Products demonstrated industrial applications in mining flotation. China is identified as the fastest-growing market with a 4.9% CAGR through 2036, while Japan leads in market value at USD 149.1 million in 2026.nutraingredients.comProactive healthy aging: Science-backed ingredients for longevity and wellnessGencor, a nutraceuticals supplier, has positioned itself as a leader in longevity-focused ingredients with over 80 clinical studies and partnerships with Pharmako Biotechnologies to enhance bioavailability of supplements. According to Vitamin Shoppe's 2025 Trends Report, 43% of consumers now use vitamins and supplements for longevity, while cellular health and healthy aging categories grew 91% in Q1. The article highlights Gencor's portfolio of proprietary ingredients including HydroCurc, PlexoZome NR, VeriSperse, AquaCelle Omega-3, Levagen+, Testofen, and Libifem, designed to address various aspects of healthy aging such as mobility, cognitive support, and hormonal balance.SupplysidesjSaffron extract eases mild depression in studyA 12-week placebo-controlled trial published in the Journal of Nutrition found that Pharmactive's branded saffron extract Affron significantly improved symptoms of mild depression in over 200 healthy adult participants, with 72% of the saffron group showing improvement versus 54% in the placebo group and a 53% reduction in low mood symptoms. The ingredient is distributed in North American markets by Gencor Pacific, and researchers identified large placebo responses as a confounding factor requiring consideration in future trials.nutraingredients.comJoint health trends: Major industry players see growing interest beyond senior consumersLonza and Gencor report a significant shift in joint health research and consumer interest, with millennials and Gen-Z now showing nearly equal interest to baby boomers. The industry is expanding focus beyond age-related degeneration to support active lifestyles among younger demographics, driving demand for ingredients with faster efficacy claims. Companies are increasingly conducting clinical trials on healthy young adults to substantiate these proactive health benefits.